Skip to main content
. 2017 Nov 7;6(11):e007253. doi: 10.1161/JAHA.117.007253

Figure 3.

Figure 3

Bar graphs depict the concentration‐dependent effects of SDF‐1α (stromal cell‐derived factor 1α; 1, 3, and 10 nmol/L) on cell number (A and B), 3H‐leucine incorporation (C and D), and 3H‐proline incorporation (E and F) in cardiac fibroblasts (CFs) from spontaneously hypertensive rats (SHR; A, C, and E) and normotensive Wistar–Kyoto rats (WKY; B, D, and F) in the absence and the presence of sitagliptin (1 μmol/L). Each P value at the top of each main panel is the 3‐way interaction P value from a 3‐factor ANOVA. These P values demonstrate that the strain from which the cells were derived (SHR vs WKY) interacts with sitagliptin to determine the overall effects of SDF‐1α on cell number, 3H‐leucine incorporation, and 3H‐proline incorporation. Each P value at the top of each subpanel is the 2‐way interaction P value from a 2‐factor ANOVA. These P values demonstrate that for all 3 variables and for both SHR and WKY CFs, sitagliptin augmented responses to SDF‐1α. *Significant difference (P<0.05; Fisher least significant difference test) between the indicated concentration of SDF‐1α and the basal values (ie, values in the absence of SDF‐1α) for the indicated variable. Significant difference (P<0.05; Fisher least significant difference test) between sitagliptin‐treated and non–sitagliptin‐treated cells at the indicated concentration of SDF‐1α. Values are means and SEM.